GLP-1 receptor raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-06-13 and is reviewed periodically as new material appears.
Retatrutide is an investigational peptide developed by a pharmaceutical company as a multi-receptor agonist for treating obesity and type 2 diabetes. The compound emerged from research into gut-hormone analogues that act on several receptors simultaneously rather than on a single target. Early preclinical work examined how combined activity at three distinct receptors might produce greater metabolic effects than single-receptor compounds. Published phase 2 results have described substantial reductions in body weight among participants, although the compound remains unapproved in most jurisdictions as of the mid-2020s.
Pharmacologically, retatrutide acts as a triple agonist at the glucagon-like peptide-1 receptor, the glucose-dependent insulinotropic polypeptide receptor, and the glucagon receptor. Activation of the first two receptors is associated with improved insulin secretion and reduced appetite. The glucagon receptor component is thought to increase energy expenditure, a mechanism that distinguishes this molecule from dual-agonist compounds. Researchers continue to investigate how the three activities interact and whether the combined profile offers advantages that justify additional clinical testing.
Several questions about the compound remain unresolved. The durability of weight reduction after treatment stops, the frequency of gastrointestinal side effects, and the long-term cardiovascular profile are topics of ongoing study. Regulatory submissions and phase 3 trial outcomes have not been fully reported in the public literature. Because most available data come from controlled trials rather than general-population use, conclusions about effectiveness outside study settings are provisional. The distinction between established findings and open questions matters when interpreting early coverage of the drug.
化学修饰延长了分子在体内的停留时间，使较低频次的给药安排成为可能。脂肪酸侧链通过与白蛋白结合延缓清除，非天然氨基酸则降低酶解速率。这些修饰同时改变分子的溶解性与稳定性，需要在制剂设计和储存条件中一并考虑。修饰引入的免疫原性风险也属于开发过程中需要评估的项目。
该化合物处于临床试验阶段，尚未在多数地区取得上市许可。公开信息主要来自企业公告、学术会议摘要与试验注册平台记录，完整数据仍在逐步披露。关于长期疗效与安全性的判断，需要等待规模更大、随访更久的研究结果，目前不宜对最终结论作出预判。
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Contains non-natural residues |
| Receptor targets | GLP-1, GIP, glucagon | Triple agonist profile |
| Route of administration | Subcutaneous injection | In clinical trial settings |
| Development status | Investigational | Not approved in major markets |
| Approximate molecular mass | About 4.7 kDa | Peptide-scale molecule |
== External links == "The Science of Drug Use: A Resource for the Justice Sector". www.drugabuse.gov. North Bethesda, Maryland: National Institute on Drug Abuse. 26 May 2020. Retrieved 23 December 2021. School-Based Drug Abuse Prevention: Promising and Successful Programs (PDF). Ottawa, Ontario: Public Safety Canada. 31 January 2018. ISBN 978-1-100-12181-9. Archived (PDF) from the original on 19 May 2021. Retrieved 23 December 2021. {{cite book}}: |website= ignored (help) Sacco LN, Finklea K (3 May 2016). "Synthetic Drugs: Overview and Issues for Congress" (PDF). Washington, D.C.: Congressional Research Service. Archived (PDF) from the original on 8 December 2021. Retrieved 23 December 2021.
== Reception and later history == The Guimard entrances received a generally warm reception. Salvador Dalí later called them "those divine entrances to the Métro, by grace of which one can descend into the region of the subconscious of the living and monarchical aesthetic of tomorrow". By way of what became known as le style Métro, they popularized Art Nouveau, which had been a style known largely to connoisseurs of the avant garde. However, critics and many of the public were hostile to the libellules in particular, and criticized the green as "German" and the lettering as "un-French" and, according to critic André Hallays in Le Temps, "confus[ing to] little children who are trying to learn their letters and ... stupefy[ing to] foreigners". On the Champs-Élysées, for example at Marbeuf (now part of Franklin D. Roosevelt), simple stone walls with discreet carved signage were used instead, and a plain design was also used at Bourse. Unhappiness with Guimard's 1904 design for the Opéra station, described in Le Figaro as having "contorted ramps" and "enormous frog-eye lamps", and increasing costs led to the CMP severing its relationship with him. The entrance at Opéra was instead designed by Joseph-Marie Cassien-Bernard, in classical marble. The CMP bought Guimard's molds and rights and a total of 141 of his entrances were ultimately produced, the last in 1913.
=== Differential diagnosis === 6-phosphogluconate dehydrogenase (6PGD) deficiency has similar symptoms and is often mistaken for G6PD deficiency, as the affected enzyme is within the same pathway; however, these diseases are not linked and can be found within the same person.
Sources: en.wikipedia.org
== Honours and awards == Commonwealth Scholar at Trinity College, Cambridge, 1960-1963 Powell Prize for English Verse, Trinity College, 1961 Vidya Jyothi from the President of Sri Lanka, 1992 Honorary DLitt, Sōka University (Japan), 1996 Doctor of Science (honoris causa), University of Ruhuna, Sri Lanka, 2004 Visiting By-Fellowship, visiting scholar, Churchill College, Cambridge, England 2015/16 Ada Derana Sri Lankan of the Year 2017 - Global Scientist Wickramasinghe was appointed Member of the Order of the British Empire (MBE) in the 2022 New Year Honours for services to science, astronomy and astrobiology.
Other 1,2- and 1,3-dithiols give related 1,3-dithiolanes (five-membered) and 1,3-dithianes (six-membered rings). Diols such as ethylene glycol undergo analogous reactions to give 1,3-dioxolanes. One distinguishing feature of the dithiolanes and dithianes derived from aldehydes is that the methyne group can be deprotonated and the resulting carbanion alkylated. 1,2-Ethanedithiol has been used as a scavenger in peptide cleavage synthesis. Like 1,3-propanedithiol, 1,2-ethanedithiol readily forms metal thiolate complexes. Illustrative is the synthesis of the derivative diiron ethanedithiolate hexacarbonyl upon reaction with triiron dodecacarbonyl:
Meanwhile, Eric preemptively gets Harper fired from Pierpoint for forging her college transcripts, thereby protecting her from insider trading charges tied to her helping Jesse. Jesse does not appear in series 3, but is mentioned to be serving a 24-month prison sentence for tax evasion. At the end of series 3, Harper reads a news story reporting that Jesse has been released.
Sources: en.wikipedia.org
It is designed as a triple agonist acting on the GLP-1, GIP, and glucagon receptors. This combination is intended to influence appetite, insulin secretion, and energy expenditure. Single-receptor and dual-receptor compounds act on a narrower set of targets.
No. It remains investigational, and phase 3 results have not been fully published or reviewed by regulators. Official approval status should be confirmed through regulatory agencies rather than secondary sources.
The added glucagon receptor activity is the main difference in its mechanism. Whether that addition produces meaningful benefits in clinical outcomes is still being studied. Comparisons between compounds rest largely on indirect rather than head-to-head trial data.
指同一个分子能激活 GIP、GLP-1 和胰高血糖素三类受体。它与只激活一到两种受体的同类分子在设计思路上有所区别。这种设计的目的在于覆盖更多代谢调节通路。